
Lincoln Pharmaceuticals Share Price
₹567.10 +2.65 (0.47%)
22 Feb, 2025 21:47
Start SIP in
LINCOLN
Performance
- Low
- ₹556
- High
- ₹583
- 52 Week Low
- ₹535
- 52 Week High
- ₹980
- Open Price₹563
- Previous Close₹564
- Volume78,629
Investment Returns
- Over 1 Month -26.37%
- Over 3 Month -8.12%
- Over 6 Month -20.69%
- Over 1 Year -17.37%
Smart Investing Starts Here Start SIP with Lincoln Pharmaceuticals for Steady Growth!
Lincoln Pharmaceuticals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 12.7
- PEG Ratio
- 5.3
- Market Cap Cr
- 1,136
- P/B Ratio
- 1.8
- Average True Range
- 42.01
- EPS
- 44.62
- Dividend Yield
- 0.3
- MACD Signal
- -41.05
- RSI
- 29.78
- MFI
- 29.62
Lincoln Pharmaceuticals Financials
Lincoln Pharmaceuticals Technicals
EMA & SMA
Current Price
₹567.10
+
2.65
(0.47%)

-
- Bullish Moving Average 0
-
- Bearish Moving Average 16
- 20 Day
- ₹649.03
- 50 Day
- ₹704.96
- 100 Day
- ₹715.30
- 200 Day
- ₹691.21
Resistance and Support
568.62
- R3 607.98
- R2 595.37
- R1 581.23
- S1 554.48
- S2 541.87
- S3 527.73
Lincoln Pharmaceuticals Corporate Actions - Bonus, Splits, Dividends
Date | Purpose | Remarks |
---|---|---|
2025-02-13 | Quarterly Results | |
2024-11-14 | Quarterly Results | |
2024-08-08 | Quarterly Results | |
2024-05-16 | Audited Results & Final Dividend | |
2024-02-08 | Quarterly Results |
Lincoln Pharmaceuticals F&O
About Lincoln Pharmaceuticals
- NSE Symbol
- LINCOLN
- BSE Symbol
- 531633
- Managing Director
- Mr. Mahendra G Patel
- ISIN
- INE405C01035
Similar Stocks to Lincoln Pharmaceuticals
Lincoln Pharmaceuticals FAQs
Lincoln Pharmaceuticals share price is ₹567 As on 22 February, 2025 | 21:33
The Market Cap of Lincoln Pharmaceuticals is ₹1135.9 Cr As on 22 February, 2025 | 21:33
The P/E ratio of Lincoln Pharmaceuticals is 12.7 As on 22 February, 2025 | 21:33
The PB ratio of Lincoln Pharmaceuticals is 1.8 As on 22 February, 2025 | 21:33
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.